(lp0
S"Here's Why the Best Is Yet to Come for Ionis Pharmaceuticals, Inc. Motley Fool - Apr 13, 2017 Ionis recently announced plans to spin off its cardiovascular drugs, including volanesorsen and the Novartis-partnered drugs, into a separate company called Akcea. Ionis will get royalties ranging from the mid-teens to the mid-20s on the drug as well ..."
p1
aS"Is Ionis Pharmaceuticals Ready To Pop? Seeking Alpha - Apr 10, 2017 Ionis Pharmaceuticals  is a biotech company which develops RNA-targeted therapeutics and has been operating for over 26 years.Ionis Pharmaceuticals Inc  Receives $42.93 Average Price Target from ... - The Cerbat GemFriday Stock Price Swings: Ionis Pharmaceuticals, Inc.'s  - Is stories"
p2
aS'Better Buy: Ionis Pharmaceuticals, Inc. vs. Juno Therapeutics Motley Fool - Mar 21, 2017 If you enjoy cutting-edge medicine, Ionis Pharmaceuticals Inc  and Juno Therapeutics Inc  are two biotech stocks that belong on your radar.'
p3
aS"Ionis Pharmaceuticals Inc. Doesn't Want to Sell Drugs  Motley Fool - Mar 28, 2017 Brian Orelli has no position in any stocks mentioned. The Motley Fool owns shares of and recommends Biogen, Celgene, Gilead Sciences, and Ionis Pharmaceuticals. The Motley Fool has the following options: short June 2017 $70 calls on GILD. The Motley&nbsp;..."
p4
aS'Ionis Pharmaceuticals to Present at Needham Healthcare Conference Yahoo Finance - Mar 29, 2017 CARLSBAD, Calif., March 29, 2017 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. , the leader in antisense therapeutics, today announced that management will present at the 16th Annual Needham Healthcare Conference on Wednesday, April 5, 2017 in&nbsp;...Hot Stock Update: Ionis Pharmaceuticals, Inc.  - HugoPressBuy, Sell or Hold? Analysts Approach: Ionis Pharmaceuticals, Inc. (IONS ... - The USA Commerce'
p5
aS"Featured Stock to See: Ionis Pharmaceuticals, Inc.  HugoPress - 22 hours ago Goldman Sachs Downgrades Ionis Pharmaceuticals, Inc. 's stock to Sell with the price target of $25. This rating was issued on 3/10/17.How Technical Indicators Have Come Out? - CytomX Therapeutics, Inc. (CTMX ... - Post AnalystIonis Pharmaceuticals Inc  Given Consensus Recommendation of &quot;Hold&quot; by ... - Markets Daily"
p6
aS"Why Ionis Pharmaceuticals Dropped 18.7% in March Motley Fool - Apr 4, 2017 After phase 3 data for its volanesorsen revealed some cases of low platelet counts, Goldman Sachs cut its rating on the company, and management announced a spin-off of some of its drugs, Ionis Pharmaceuticals  shares declined 18.7% in&nbsp;...Most Recent Stock Movements: Ionis Pharmaceuticals, Inc.'s  - Is storiesTechnical analysis perspective: Alnylam Pharmaceuticals, Inc. , Ionis ... - Post Analyst"
p7
aS'Akcea Initiates Phase 2 Study of AKCEA-APO-L Rx in Patients with High Lp(a ... PR Newswire  - Mar 30, 2017 CAMBRIDGE, Mass., March 30, 2017 /PRNewswire/ -- Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. , today announced the initiation of a Phase 2b dose-ranging study of AKCEA-APO-LRx in patients with&nbsp;...'
p8
aS'Investor Guide: Check on Technical Levels for Ionis Pharmaceuticals Inc  Midway Monitor - 16 hours ago One technical indicator that may assist in measuring the strength of market momentum is the Average Directional Index or ADX. At the time of writing, the 14-day ADX for Ionis Pharmaceuticals Inc  is standing at 16.78. Many chart analysts believe ...'
p9
aS"Ionis Pharmaceuticals, Inc.  Short Interest &amp; Technical Update Midway Monitor - 13 hours ago Investors are looking at Ionis Pharmaceuticals, Inc. 's short data, trying to figure out market sentiment on which way the market thinks the stock is moving."
p10
a.